RGNX (RGNX) Stock Price & Analysis
RGNX (RGNX) fell 2.83% to USD 8.94 as of September 8, 2026 at 05:51 UTC, according to Nexqual real-time market data.
RGNX last closed at USD 8.94; the session ranged USD 8.86–9.22 on volume of 1,070,570 shares. Market capitalization is —, with a 52-week range of USD 5.46–16.19 (NMS). Source: Nexqual, September 8, 2026 at 05:51 UTC.
Key Statistics (as of September 8, 2026 at 05:51 UTC)
| Price | USD 8.94 |
|---|---|
| Change | ▼ 2.83% (down) |
| Previous Close | USD 8.94 |
| Open | USD 8.94 |
| Day Range | USD 8.86 – 9.22 |
| 52-Week Range | USD 5.46 – 16.19 |
| Volume | 1,070,570 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RGNX)
Nexqual's technical model rates RGNX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.21 (neutral) |
| vs SMA50 | Below (USD 10.95) |
| MACD | -0.39 (negative) |
From RGNX's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | USD 3.51 | ▼ 0.85% |
| QURE | uniQure N.V. | USD 44.5 | ▼ 3.74% |
| MGTX | MeiraGTx Holdings plc | USD 13.89 | ▼ 1.21% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 15.3 | ▼ 42.33% |
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:51 UTC. This page is informational and not investment advice.